Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
Frontiers in Oncology|October 31, 2022
Clinical characteristics and prognosis of 16 relapsed/refractory B-cell malignancy patients with CAR T-cell-related hyperferritinaemiaLanlan Zhou, Nanzhou Yu, Tongjuan Li, et al.
American Journal of Cancer Research|August 10, 2023
Broad spectrum integrin inhibitor GLPG-0187 bypasses immune evasion in colorectal cancer by TGF-β signaling mediated downregulation of PD-L1William J MacDonald, Brooke Verschleiser, Lindsey Carlsen, et al.
American Journal of Cancer Research|February 10, 2022
Colorectal cancer extracellular acidosis decreases immune cell killing and is partially ameliorated by pH-modulating agents that modify tumor cell cytokine profilesKelsey E Huntington, Anna Louie, Lanlan Zhou, et al.
Cancer Biology & Therapy|November 13, 2015
Regorafenib with a fluoropyrimidine for metastatic colorectal cancer after progression on multiple 5-FU-containing combination therapies and regorafenib monotherapyEric I Marks, Carlyn Tan, Jun Zhang, et al.
Scientific Reports|October 23, 2021
Anti-cancer efficacy including Rb-deficient tumors and VHL-independent HIF1α proteasomal destabilization by dual targeting of CDK1 or CDK4/6 and HSP90Shuai Zhao, Lanlan Zhou, David T Dicker, et al.
Oncotarget|October 22, 2021
Hyperprogression of a mismatch repair-deficient colon cancer in a humanized mouse model following administration of immune checkpoint inhibitor pembrolizumabIlyas Sahin, Andrew George, Shengliang Zhang, et al.
Metabolism: Clinical and Experimental|January 17, 2016
Type 2 diabetes mitigation in the diabetic Goto-Kakizaki rat by elevated bile acids following a common-bile-duct surgeryFeng Gao, Xu Zhang, Lanlan Zhou, et al.
Frontiers in Pharmacology|October 11, 2021
Targeting the Integrated Stress Response in Cancer TherapyXiaobing Tian, Shengliang Zhang, Lanlan Zhou, et al.
Brain, Behavior, and Immunity|December 3, 2017
Platelet glycoprotein receptor Ib blockade ameliorates experimental cerebral ischemia-reperfusion injury by strengthening the blood-brain barrier function and anti-thrombo-inflammatory propertyChunyan Chen, Tingting Li, Yuchen Zhao, et al.
International Immunopharmacology|March 17, 2023
Activation of the Epac/Rap1 signaling pathway alleviates blood-brain barrier disruption and brain damage following cerebral ischemia/reperfusion injuryXuemei Sun, Yingnan Wang, Yuchen Zhao, et al.
Pageof 11